Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
PCSC’s GDP Program Adds Four Accredited Companies
The Healthcare Distribution Alliance’s (HDA) Pharmaceutical Cargo Security Coalition (PCSC) announced its Good Distribution Practices (GDP) Accreditation Program has accredited four new companies.
HDA Statement on the PREVENT Pandemics Act
The Healthcare Distribution Alliance (HDA) applauds the leadership of Senate Health, Education, Labor, and Pensions (HELP) Committee’s Chairwoman Murray (D-Wash.) and Ranking Member Burr (R-N.C.) for introducing the Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act (PREVENT Pandemics Act), a bipartisan public health effort to build stronger national medical preparedness and response systems in the wake of the COVID-19 pandemic. The overwhelming support for the legislation during the HELP Committee markup today, March 15, showed that Congress is making significant, positive steps towards reforms necessary to ensure the availability of lifesaving pharmaceutical treatments and medical supplies in response to future crises.
Kaminsky and Hatcher To Lead HDA Board of Directors; Syvinski Appointed to Executive Committee
The Healthcare Distribution Alliance (HDA) announced Kirk Kaminsky and Jody Hatcher will serve a second year as Chairman and Vice Chairman, respectively, of the HDA Board of Directors.
HDA’s President and CEO Chester “Chip” Davis, Jr., Testifies Before House Energy and Commerce Health Subcommittee on Generic Drug Shortages
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., testified before the House Energy and Commerce Subcommittee on Health during a legislative hearing on proposals to prevent and respond to generic drug shortages.